"Retina and Macula Specialists are experts in the diagnosis and treatment of medical and surgical conditions of the vitreous, retina and macula"

During the past decade, Retina and Macula Specialists conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Retina and Macula Specialists" are "Geographic Atrophy" (1 trials), "Macular Degeneration" (1 trials) and "Neovascular Age-related Macular Degeneration (nAMD)" (1 trials). Many other conditions were trialed in "Retina and Macula Specialists" in a lesser frequency.

Most popular intervention types in "Retina and Macula Specialists" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "IONIS-FB-LRx" (1 trials), "Placebo" (1 trials), "Port Delivery System with Ranibizumab" (1 trials) and "Ranibizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Retina and Macula Specialists" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Retina and Macula Specialists". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Retina and Macula Specialists, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Retina and Macula Specialists, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".